93 related articles for article (PubMed ID: 14600649)
1. Gene profiling of lymphoma, myeloma, and AML.
Rogge L; Bianchi E
MedGenMed; 2003 Jul; 5(3):12. PubMed ID: 14600649
[No Abstract] [Full Text] [Related]
2. A gene selection algorithm based on the gene regulation probability using maximal likelihood estimation.
Wang HQ; Huang DS
Biotechnol Lett; 2005 Apr; 27(8):597-603. PubMed ID: 15973495
[TBL] [Abstract][Full Text] [Related]
3. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
Downing JR
Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
[TBL] [Abstract][Full Text] [Related]
4. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.
Duque RE; Andreeff M; Braylan RC; Diamond LW; Peiper SC
Cytometry; 1993; 14(5):492-6. PubMed ID: 8354121
[No Abstract] [Full Text] [Related]
5. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling and multiple myeloma.
Shaughnessy J; Zhan F; Barlogie B; Stewart AK
Best Pract Res Clin Haematol; 2005; 18(4):537-52. PubMed ID: 16026736
[TBL] [Abstract][Full Text] [Related]
7. [The diagnosis of acute myeloid leukaemia enhanced by using DNA microarrays].
Löwenberg B; Delwel HR; Valk PJ
Ned Tijdschr Geneeskd; 2005 Mar; 149(12):623-5. PubMed ID: 15813428
[TBL] [Abstract][Full Text] [Related]
8. Insights from the gene expression profiling of multiple myeloma.
Claudio JO; Masih-Khan E; Stewart AK
Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
[TBL] [Abstract][Full Text] [Related]
9. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
Rücker FG; Bullinger L; Schwaenen C; Lipka DB; Wessendorf S; Fröhling S; Bentz M; Miller S; Scholl C; Schlenk RF; Radlwimmer B; Kestler HA; Pollack JR; Lichter P; Döhner K; Döhner H
J Clin Oncol; 2006 Aug; 24(24):3887-94. PubMed ID: 16864856
[TBL] [Abstract][Full Text] [Related]
10. Tracing the origin of cytogenetic anomalies in acute myeloid leukaemia following multiple myeloma.
Georgia S; Dieter-Kurt H
Br J Haematol; 2004 Aug; 126(4):442. PubMed ID: 15287936
[No Abstract] [Full Text] [Related]
11. Further insights into multiple myeloma genetics.
Drach J
Haematologica; 2006 Feb; 91(2):147a. PubMed ID: 16461292
[No Abstract] [Full Text] [Related]
12. Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.
Lindvall C; Furge K; Björkholm M; Guo X; Haab B; Blennow E; Nordenskjöld M; Teh BT
Haematologica; 2004 Sep; 89(9):1072-81. PubMed ID: 15377468
[TBL] [Abstract][Full Text] [Related]
13. High expression of EDAG and its significance in AML.
An LL; Li G; Wu KF; Ma XT; Zheng GG; Qiu LG; Song YH
Leukemia; 2005 Aug; 19(8):1499-502. PubMed ID: 15920494
[No Abstract] [Full Text] [Related]
14. Cancer: An unexpected addiction.
Shaughnessy JD
Nature; 2008 Jul; 454(7201):172-3. PubMed ID: 18615074
[No Abstract] [Full Text] [Related]
15. [Gene expression analysis of AML cells using cDNA microarray].
Okutsu J; Nakamura Y
Rinsho Ketsueki; 2002 May; 43(5):319-22. PubMed ID: 12096477
[No Abstract] [Full Text] [Related]
16. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
17. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.
Verhaak RG; Wouters BJ; Erpelinck CA; Abbas S; Beverloo HB; Lugthart S; Löwenberg B; Delwel R; Valk PJ
Haematologica; 2009 Jan; 94(1):131-4. PubMed ID: 18838472
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
19. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
20. Chromosomes and cloning efficiencies of hematopoietic cell lines derived from patients with leukemia, melanoma, myeloma, and Burkitt lymphoma.
Huang CC; Imamura T; Moore GE
J Natl Cancer Inst; 1969 Nov; 43(5):1129-46. PubMed ID: 5260617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
